Journal
JOURNAL OF IMMUNOLOGY
Volume 177, Issue 5, Pages 2959-2968Publisher
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.177.5.2959
Keywords
-
Categories
Funding
- NHLBI NIH HHS [HL-55967] Funding Source: Medline
- NIAID NIH HHS [AI35726, AI-45244/95383, N01-AI-40091, AI34343, AI-27243] Funding Source: Medline
Ask authors/readers for more resources
The pathological hallmark of the host response to Mycobacterium tuberculosis is the granuloma where T cells and macrophages interact with the extracellular matrix (ECM) to control the infection. Recruitment and retention of T cells within inflamed tissues depend on adhesion to the ECM. T cells use integrins to adhere to the ECM, and fibronectin (FN) is one of its major components. We have found that the major M. tuberculosis cell wall glycolipid, phosphatidylinositol mannoside (PIM), induces homotypic adhesion of human CD4(+) T cells and T cell adhesion to immobilized FN. Treatment with EDTA and cytochalasin D prevented PENI-induced T cell adhesion. PIM-induced T cell adhesion to FN was blocked with mAbs against alpha(5) integrin chain and with RGD-containing peptides. alpha(5)beta(1), (VLA-5) is one of two major FN receptors on T cells. PIM was found to bind directly to purified human VLA-5. Thus, PIM interacts directly with VLA-5 on CD4(+) T lymphocytes, inducing activation of the integrin, and promoting adhesion to the ECM glycoprotein, FN. This is the first report of direct binding of a M. tuberculosis molecule to a receptor on human T cells resulting in a change in CD4(+) T cell function.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available